Uncover key drivers, emerging technologies, and competitive movements shaping the gastric cancer diagnostic market from 2025–2034 with trusted insights from The Business Research Company

What Are The Market Size Estimates For The Gastric Cancer Diagnostic Market?

The gastric cancer diagnostic market size has witnessed strong growth in recent years. It is anticipated to expand from $2.59 billion in 2024 to $2.78 billion in 2025, achieving a compound annual growth rate (CAGR) of 7.3%. This historical growth can be attributed to factors like the increasing prevalence of Helicobacter pylori infection, rising awareness regarding gastric cancer symptoms, a growing incidence of gastric cancer within aging populations, increased consumption of smoked and preserved foods, and the expanding utilization of diagnostic screening among high-risk demographics.

The gastric cancer diagnostic market is expected to experience substantial growth in the upcoming years, projected to reach $3.63 billion by 2029, at a compound annual growth rate (CAGR) of 6.9%. This expansion over the forecast period is attributed to several factors, including an increasing demand for early detection and screening programs, rising awareness campaigns targeting gastric cancer prevention, the growing adoption of personalized medicine approaches, enhancing healthcare infrastructure development in emerging markets, and a heightened focus on non-invasive and rapid diagnostic tests. Key trends anticipated during this period involve technological advancements in molecular diagnostics, the development of biomarker panels to improve diagnostic accuracy, the creation of portable diagnostic devices for point-of-care testing, the innovation of minimally invasive diagnostic tools, and the integration of various imaging modalities.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27291&type=smp

Which Industry Forces Are Driving The Gastric Cancer Diagnostic Market Forward?

The increasing prevalence of gastric cancer is projected to fuel the expansion of the gastric cancer diagnostic market moving forward. Gastric cancer describes a malignant tumor in the stomach’s inner lining, where cells multiply without control, forming a mass that can penetrate nearby tissues and disseminate to other body parts. This rise in incidence is attributed to unhealthy eating patterns, as a high intake of salted, smoked, and processed foods escalates damage to the stomach lining and increases cancer risk. Gastric cancer diagnostic tools assist in its diagnosis by allowing for the early detection of malignant lesions, which is crucial for timely intervention and improved patient results. These tools enhance clinical efficacy by offering accurate and rapid findings, supporting superior disease management. For instance, in May 2024, the American Cancer Society, a US-based nonprofit organization, reported 26,890 new stomach cancer cases in 2024, an increase from 26,500 cases in 2023. Thus, the escalating incidence of gastric cancer is a key driver for the growth of the gastric cancer diagnostic market.

How Is The Gastric Cancer Diagnostic Market Organized By Different Segments?

The gastric cancer diagnostic market covered in this report is segmented

1) By Diagnostic Type: Endoscopy, Imaging, Biopsy, Laboratory Tests, Biomarker-Based Testing

2) By Product: Reagents And Consumables, Instruments

3) By Technology: Molecular Diagnostics, Immunoassays, Next-Generation Sequencing, Other Technologies

4) By Application: Early Diagnosis, Screening, Monitoring

5) By End User: Hospitals, Clinics, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Endoscopy: Conventional Endoscopy, Chromoendoscopy, Narrow Band Imaging, Confocal Laser Endomicroscopy, Capsule Endoscopy

2) By Imaging: Computed Tomography, Magnetic Resonance Imaging, Positron Emission Tomography, Ultrasound

3) By Biopsy: Forceps Biopsy, Needle Biopsy, Endoscopic Ultrasound-Guided Biopsy, Laparoscopic Biopsy

4) By Laboratory Tests: Blood Tests, Stool Tests, Urea Breath Test, Serology

5) By Biomarker-Based Testing: Genetic Testing, Protein Biomarker Testing, Circulating Tumor DNA Testing, Microribonucleic Acid Testing

What Current And Upcoming Trends Are Shaping The Gastric Cancer Diagnostic Market?

Leading companies in the gastric cancer diagnostic market are prioritizing the development of innovative diagnostic instruments, such as artificial intelligence-based endoscopic diagnostic support devices, to improve early detection and precision. These artificial intelligence-based endoscopic diagnostic support devices are AI-driven tools that assist in identifying and assessing gastrointestinal anomalies during endoscopy. For example, in March 2024, AI Medical Service Inc., a Japan-based medical technology company, introduced GastroAI-model G, an AI-powered endoscopic diagnostic support system. This system aids gastroenterologists during endoscopic procedures by analyzing video images in real time to pinpoint potential cancerous lesions. It leverages deep learning to detect suspicious areas indicative of early gastric cancer, which might require a biopsy or further examination. When such lesions are identified, the system immediately alerts the physician by highlighting the region with a rectangle on the endoscopic screen, thereby enhancing diagnostic accuracy and enabling the early discovery of cancer.

Who Are The Primary Market Leaders In The Gastric Cancer Diagnostic Market?

Major companies operating in the gastric cancer diagnostic market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., bioMérieux SA, Qiagen N.V., DiaSorin S.p.A, Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Foundation Medicine Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Fujirebio Inc., MiRXES Pte Ltd., BIOCEPT Inc., Pillar Biosciences Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/gastric-cancer-diagnostic-global-market-report

How Do Regional Dynamics Influence The Gastric Cancer Diagnostic Market Performance?

North America was the largest region in the gastric cancer diagnostic market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastric cancer diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=27291&type=smp

Browse Through More Reports Similar to the Global Gastric Cancer Diagnostic Market 2025, By The Business Research Company

Mineral Wool Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/mineral-wool-global-market-report

Building Insulation Materials Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/building-insulation-materials-global-market-report

Insulation Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/insulation-products-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model